Our Clinical Sites and Trials

Trials Sites

Results

Enter location to sort by distance.

Trial

Research Area

Duration

Locations

A5356: A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination with a Short Course Regimen for the Treatment of Drug-Resistant Tuberculosis

Open and enrolling

Tuberculosis

See locations
A5300B/I2003B:Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Participants (PHOENIx)

This trial is in household contacts (HHC) at high risk for developing multidrug resistant tuberculosis (MDR-TB) which is an infection…

Open and enrolling

Tuberculosis

All participants will be in this study for 96 weeks.

See locations